Circulating CTLA-4 levels and CTLA4 polymorphisms associate with disease condition and progression and hepatocellular carcinoma patients' survival in chronic hepatitis B virus infection

Wang, L; Li, N; Fan, XD; Wang, XY; Zhang, XG; Zhang, K; Han, QY; Lv, Y; Liu, ZW

Liu, ZW (corresponding author), Xi An Jiao Tong Univ, Dept Infect Dis, Affiliated Hosp 1, 277 Yanta West Rd, Xian 710061, Shaanxi, Peoples R China.

INTERNATIONAL IMMUNOPHARMACOLOGY, 2020; 82 ():

Abstract

Background: CTLA-4 is involved in the immune dysfunction of hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC). This study analyzed ......

Full Text Link